Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to $109.5 million.

  • Roivant Sciences' Cash from Investing Activities rose 10385.39% to $109.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.7 billion, marking a year-over-year decrease of 29391.62%. This contributed to the annual value of -$1.8 billion for FY2025, which is 13394.35% down from last year.
  • Per Roivant Sciences' latest filing, its Cash from Investing Activities stood at $109.5 million for Q4 2025, which was up 10385.39% from $120.4 million recorded in Q3 2025.
  • Roivant Sciences' Cash from Investing Activities' 5-year high stood at $5.2 billion during Q4 2023, with a 5-year trough of -$3.3 billion in Q3 2024.
  • In the last 5 years, Roivant Sciences' Cash from Investing Activities had a median value of -$2.3 million in 2021 and averaged -$101.2 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first skyrocketed by 339275.7% in 2023, then crashed by 11240943.01% in 2025.
  • Roivant Sciences' Cash from Investing Activities (Quarter) stood at $309.0 million in 2021, then plummeted by 151.08% to -$157.8 million in 2022, then surged by 3392.76% to $5.2 billion in 2023, then tumbled by 154.66% to -$2.8 billion in 2024, then skyrocketed by 103.85% to $109.5 million in 2025.
  • Its Cash from Investing Activities was $109.5 million in Q4 2025, compared to $120.4 million in Q3 2025 and -$1.1 billion in Q2 2025.